一个患有Mahvash疾病的妇女的肝脏移植
Justin Robbins1, Dina Halegoua-DeMarzio1, Atrayee Basu Mallick1
1From the Department of Internal Medicine (J.R., M.D.), the Division of Gastroenterology and Hepatology (D.H.-D., T.S.), the Department of Medical Oncology, Sidney Kimmel Cancer Center (A.B.M., D.S.L.), the Department of Surgery (H.L., W.M., A.P.S.), the Division of Endocrinology, Diabetes, and Metabolic Diseases (J.M.), and the Department of Pathology and Genomics (M.A.), Thomas Jefferson University, the Department of Medical Oncology, Fox Chase Cancer Center (N.V.), and the Division of Human Genetics, Children's Hospital of Philadelphia (R.G.) - all in Philadelphia; the Division of Clinical Cancer Genetics, Section of Medical Oncology, Department of Medicine, Yale School of Medicine and Yale Cancer Center, New Haven, CT (V.N.G.); and the Division of Endocrinology, Diabetes, and Metabolism, David Geffen School of Medicine at UCLA, Los Angeles (R.Y.).
马哈瓦什病是一种罕见的遗传性疾病,可导致门门高血压. 肝移植有效治疗患者,使葡萄糖水平正常化并解决并发症.
科学领域:
- 内分泌学 在内分泌学.
- 肝病学 肝病学是一种肝病学.
- 遗传学 遗传学 是一个
背景情况:
- 马瓦什病是一种罕见的遗传性疾病,影响葡萄糖信号传递,其特征是高葡萄糖血症,高氨基酸血症和胰腺α细胞增生.
- 目前的治疗主要集中在症状控制上,使用八二来降低葡萄糖水平,但没有确定的治疗方法.


